51 results about "Terminal cancer" patented technology

The invention relates to an external drug for eliminating cancer tumor bumps and alleviating pains thereof, which belongs to the field of medicine and overcomes the disadvantages that the prior anodyne for terminal cancer has drug addiction and gradually reduced pains alleviating effect. The external drug consists of asafetida, dried lacquer, poison nut, blood clam shell, pangolin, hirudo, gadfly, soil insect, rhizoma corydalis, frankincense, myrrh, rhizoma sparganii, zedoary, rhizoma ligustici wallichii, notoginseng, dragon's blood, hedgehog skin, peach kernel, safflower, radix aconiti, radix aconiti feri, scorpion, centipede, snake skin, oldenlandia diffusa, glabrous greenbrier rhizome, ginseng, radix astragali, american ginseng, angelica, radix salviae miltiorrhizae, muskiness and the like. The external drug has the advantages that the drug can eliminae or obviously alleviate pains of complication of the terminal cancer, has stable analgesic effect, and has no side effects compared with the prior anodyne used for the same disease symptom.

The invention discloses a traditional Chinese patent medicine with the components of plant polysaccharide and bamboo extract for treating medium and terminal cancer, which has a formula as follow: 10 kg of whangee, 5 kg of CV.Ventricousinternode, 10 kg of moso bamboo, 5 kg of palm bamboo, 5 kg of phyllostachys glauca, 10 kg of fishscale bamboo and 5 kg of fortune paulownia bark. A method for preparing the traditional Chinese patent medicine comprises the following steps: adding 50 kg of water into the total 50 kg of the medical materials; decocting the mixture to obtain 200 ml to 400ml of concentrated material; adding mineral trace elements: 0.01 milligrams of calcium, 0.01 milligrams of ferrum, 0.01 milligrams of zinc, 0.01 milligrams of selenium, 0.01 milligrams of iodine and 0.01 milligrams of potassium which are essential to the body into the concentrated material after removing impurities and filtering; finally, fermenting the final mixture to obtain the medicine, and bottling the medicine for use. The traditional Chinese patent medicine has the beneficial effects of treating medium and terminal esophagus cancer, gastric cancer, intestinal cancer, liver cancer, cerebral cancer and other cancers and treating gastritis, gastric ulcer, hepatitis, rhinitis and other inflammation. In addition, the traditional Chinese patent medicine can be also used for treating skin cancer and various kinds of skin diseases by exterior spreading. The traditional Chinese patent medicine takes effect rapidly and has no toxic and side effect.

The invention relates to a preparation for treating cancer and the preparation method thereof, which is formed by panax, astragalus, ganoderma lucidum, myrobalan, Chinese chive seed, hedyotis diffusa, scullcap, smilax glabra rhizome, subprostrate soplhor root, glycyrrhiza, indico naturalis and aloe, applicable for early, middle and terminal cancer patients, with effects of anticarcinogenesis and effective strengthening the physical fitness of patients. The said preparation has effects of adjusting incretion, assisting healthy energy, enhancing immunity of the patients; eliminating the sick tendency, direct killing cancer cells; regulating stomache qi to improve the function of spleen and stomach, cleaning up the turbid qi to eliminate the sick tendency in the viscera; clearing heat and detoxicating, activating blood circulation to dissipate blood stasis, softening and resolving hard masses to perish tumour, control tumour, improve surgical treatment and remote therapeutic effect; lessening side effect, improving symptom, enhancing quality of existence and prolonging the suvival time.

The invention relates to a method for extracting a clam extract freeze-dried powder. The method is characterized by comprising the following steps: cleaning: fresh marine organism clams are cleaned to remove sludge, shells are removed, soft bodies are taken out and cleaned until no bloodiness is left and then drained, thus obtaining a clean material; mashing: particle size is between 0.2cm and 0.4cm; extracting: the clean material mashed is mixed with water by a ratio of 1:1 to 1:2 in an extraction plant for extraction for 2 hours to 6 hours at temperature between 0 DEG C and 10 DEG C, separation, centrifugation and deslagging are conducted, thus obtaining a centrifugate; and freeze-drying: the clam extract freeze-dried powder is obtained through pre-freezing and first phase and second phase of sublimation. The extraction method is simple and effective, has effective components with the high content of bioactive proteins and is used for producing clam extract enteric-coated capsules to treat early, intermediate stage and terminal cancer patients such as lung cancer, liver cancer, renal carcinoma, carcinoma ventriculi, cervical carcinoma patients and the like.

The invention provides traditional Chinese medicine for treating cancer. The traditional Chinese medicine comprises rhizoma sparganii, subprostrate sophora, the root of red-rooted salvia, radix scrophulariae, the root of straight ladybell, codonopsis pilosula, radix angelicae, angelica sinensis, the root of common peony, curcuma aromatica, radix scutellariae, poria cocos, curcuma zedoary, thunberg fritillary, the seed of garden balsam, dandelions, cortex moutan, cinnabar, eupolyphaga, trogopterus dung, flos carthami, cordyceps sinensis, manis pentadactyla, elecampane, rhizoma corydalis, leeches, earthworm and platycodon grandiflorum. By taking the traditional Chinese medicine, the immunity of a patient can be improved, the capacity of human body leukocyte for killing cancer cells can be enhanced, and the effects of viscera benefiting, excitement tranquilizing and allaying, swelling and pain relieving, qi promoting, collateral obstruction removing, lump gradual reducing, patient pain relieving, life quality improving and service life prolonging are achieved. Through improvement of the immunity of the patient, the patient can remove cancer cells by the resistance of the patient. The effect of relapse preventing can be achieved after the patient is subjected to operation, radiotherapy and chemotherapy. Pain of a terminal cancer patient can be relieved if the patient takes the medicine, and the life of the patient can be prolonged. A good curative effect can be achieved if an early cancer patient takes the medicine.

The invention provides an overturn type magnetic therapy apparatus. The overturn type magnetic therapy apparatus comprises a bed body, a machine body, a control system and a drive device, and is characterized in that the machine body comprises a machine main body as well as an upper machine head and a lower machine head mounted on the machine main body, wherein the upper machine head is positioned above the bed body, the lower machine head is positioned below the bed body, more than one magnetic head is mounted on each of the two machine heads, the more than one magnetic head on the upper machine head corresponds to the more than one magnetic head on the lower machine head, the drive device comprises a first drive mechanism for controlling the bed body and the machine body to carry out relative movement in the horizontal direction, and a second drive mechanism for controlling the more than one magnetic head on the upper machine head to turn over or rotate. The overturn type magnetic therapy apparatus has good treatment effects, is low in treatment cost and convenient to use, and is particularly suitable for the mid-term and terminal cancer patients without long-distance diffusion transfer.

The invention provides a drug clinical testing method which is in particular suitable for the clinical trials of drugs for some fatal diseases. At present, the international general drug clinical testing employs the randomized controlled double-blind trial method which is characterized in that patients are divided into a trial group and a control group, and the patients in the trial group are given a tested drug for treatment while a placebo without any curative effect is given to the patients in the control group; if the drug is aimed at curing some fatal diseases which some conventional drugs cannot cure, such as terminal cancer, it is extremely inhuman for the patients in the control group because the patients in the control group are given the placebo without any curative effect only and are destined to die of the disease. The method provided by the invention is characterized in that the patients receiving the testing can get the same drug, and only the doses are different; if the drug passes the clinical testing successfully, some patients who are not cured because of the dose difference can recover by adjusting the doses according to clinical testing results; thus, the method conforms to the revolutionary humanitarian spirit of heating the wounded and rescue the dying.

An opioid receptor agonist is a powerful effect analgesic medicine which is clinically and widely used, morphine is representative, and the medicine can effectively relieve pain of patients, particularly for pain of people after an operation and in the terminal cancer. However, opioids are easy to cause tolerance and hyperalgesia of patients, and the tolerance and the hyperalgesia can be easily formed within one week. Once the tolerance and the hyperalgesia are formed, dosage is continuously increased to continue to maintain the effect of alleviating pain, namely that organisms need a massivedose of medicines to achieve the effect of alleviating pain as the initial dose, but the higher dose can cause serious hyperalgesia, tolerance, constipation, addiction and respiratory depression. Cobra neurotoxin polypeptide can restrain the hyperalgesia and the tolerance of the opioids, and can also improve the treatment effects of opioids, and when the cobra neurotoxin polypeptide and the opioids are combined together for use, the opioids can alleviate pain at the lower dose and does not generate tolerance and hyperalgesia, so that the clinical technical problem that the opiods cannot be used for a long term can be solved.

The invention discloses a Chinese medicine composition for treating pain in the terminal cancers. The Chinese medicine composition is prepared from the Chinese medicine materials of curcuma zedoary, rhizoma sparganii, rhizoma corydalis, root of common peony, radix paeoniae alba, astragalus membranaceus, thunberg fritillary bulb, oldenlandia diffusa, polygonum cuspidatum, szechwan Chinaberry fruit, keel, root of three-nerved spicebush, cortex albiziae and liquorice according to the specified mass fraction. The Chinese medicine composition has the beneficial technical effects that common natural medicine materials are screened by the principle of combining disease differentiation of traditional Chinese medical science with discrimination according to the components of compatibility of monarch, minister, assistant and guide; and the composition is prepared from plant medicine materials as main ingredients by reasonable compatibility of a plurality of Chinese herbal medicines. A special formula of double monarch medicine materials is adopted; the Chinese medicine composition is combined with the effects of eliminating evil and strengthening the body resistance, and can treat both symptoms and root causes; and a good effect is obtained under a limited sample condition. The Chinese medicine composition is rigorous and scientific in formula and compatibility, and free of toxic and side effects under the condition that the plurality of Chinese herbal medicines are reasonably used; and a therapeutic schedule with a significant curative effect, low cost and a small side effect is provided for treatment of the pain in terminal cancers.

Cancer induced bone pain has high incidence and severe pain, is a major cause for hard control of terminal cancer pain. Opium and other analgesic drugs are prone to generate tolerance, and are associated with serious adverse responses, such as respiratory depression, drowsiness, constipation and the like, so that the quality of life is seriously affected. By means of rat tibial cancer pain model pharmacological experiments, the invention proves that: the externally used compound traditional Chinese medicine (made of Radix Aconiti, Radix Aconiti Kusnezoffii, Fructus Psoraleae, frankincense, myrrh, earthworm, dried ginger, and borneol) provided in the invention can significantly alleviate cancer induced bone pain, the economic cost is low, administration is convenient, adverse responses are fewer. Thus, the externally used compound traditional Chinese medicine is an effective assistant analgesic drug, and has good application prospects.

Belonging to the technical field of medical equipment, the invention provides abdominocentesis protective equipment for terminal cancer patients. The equipment is characterized by including a front fixed frame, a rear fixed frame, a left telescopic folding rod, a right telescopic folding rod and a lighting slip fixed functional group. The front fixed frame and rear fixed frame both include a gantry-shaped frame body, which comprises a left stand column, a right stand column and an upper cross beam. The left stand column and right stand column of the front fixed frame's gantry-shaped frame bodyare internally equipped with a second bin and a first bin respectively, and the left stand column and right stand column of the rear fixed frame's gantry-shaped frame body are internally equipped with a third bin and a fourth bin respectively. The front fixed frame and rear fixed frame are connected by the left and right telescopic folding rods respectively. And a first functional set, a second functional set, a third functional set and a fourth functional set are respectively disposed in the first bin, the second bin, the third bin and the fourth bin. The protective equipment provided by theinvention can assist the operating staff in carrying out laparoscopic puncture operation, obviously alleviates the operation fatigue and can improve the operation quality.

Cancer induced bone pain has high incidence and severe pain, is a major cause for hard control of terminal cancer pain. Opium and other analgesic drugs are prone to generate tolerance, and are associated with serious adverse responses, such as respiratory depression, drowsiness, constipation and the like, so that the quality of life is seriously affected. By means of rat tibial cancer pain model pharmacological experiments, the invention proves that: the externally used compound traditional Chinese medicine (made of Radix Aconiti, Radix Aconiti Kusnezoffii, Fructus Psoraleae, frankincense, myrrh, earthworm, dried ginger, and borneol) provided in the invention can significantly alleviate cancer induced bone pain, the economic cost is low, administration is convenient, adverse responses are fewer. Thus, the externally used compound traditional Chinese medicine is an effective assistant analgesic drug, and has good application prospects.

The invention is a Chinese medicinal anticancer anti-tumour compound preparation, having high effective concentration, strong penetrability, and strong appetency for cancer cell and applied to diagnose and cure medium-term and terminal cancer patient. It adopts purely natural bighead atractylodes rhizome without pollution, fulin, silver fern, Vitex negundo Linn. var. cannabifolia, Chinese cater-pillar fungus, pseudo-ginseng, Taipei Fritillary Bulb, dixiamingzhu, liuyuelin, baifu, shizhucao, and musk to make the preprocessing of basking, exposing and baking, then adopts the method of seven-cooling seven-boiling and the extraction separating technique to refine the Chinese medicinal effective components and separate the poisonous matters in the Chinese traditional medicine, and then eliminates the poison, purifies and refines the processed drug to obtain the powder compound preparation.

The invention discloses a compounded analgesic preparation containing cobratide and oxycodone, which includes following raw materials, by weight, 0.04-0.08 parts of the cobratide and 4-12 parts of an oxycodone active component. The oxycodone active component is the oxycodone and a pharmaceutically-acceptable salt thereof. An experimental result proves that the compounded analgesic preparation can alleviate terminal cancer pain, chronic joint pain, sciatica, neuropathic headache, prosopalgia and lepra reaction neuralgia and the like chronic pains, is especially suitable for chronic, refractory and durable pains, is quick in effect, is strong and durable in analgesic effect, can avoid or reduce addiction and dependency and is high in stability. The compounded analgesic preparation containing the cobratide and the oxycodone can be used as an ideal medicine for cancer-used analgesia.

The invention discloses a preparation formula and preparation method of a fungal medicine for treating cancer. The content thereof comprises: the total amount of free amino acids ranging from 1.2 mg / ml to 1.6 mg / ml, the total amount of hydrolyzed amino acids ranging from 5.3 mg / ml to 5.8 mg / ml, Nucleotide 0.23mg / ml to 0.27mg / ml, RNA 0.15mg / ml to 0.18mg / ml, DNA 0.10mg / ml to 0.12mg / ml, folic acid 7.0μg / ml to 7.4μg / ml, pantothenic acid 95.5μg / ml ml to 99.5μg / ml, polysaccharide 1.8mg / ml to 2.1mg / ml, vitamin B6 3.3μg / ml to 3.6μg / ml, vitamin B12 30.4μg / ml to 33.4μg / ml, copper 0.13mg / L to 0.19mg / L, etc., it can not only prevent the occurrence of cancer, but also have significant effects in alleviating various sufferings of cancer patients, improving the quality of life of cancer patients, improving the cure rate of cancer patients, and prolonging the life of cancer patients. It is especially suitable for those who are unwilling It is used for patients with advanced cancer who are undergoing radiotherapy and chemotherapy in the hospital and who cannot undergo radiotherapy and chemotherapy in the hospital because of their age or frailty.

Constipation is a common and serious problem for terminal cancer patients, often resulting in deterioration of the overall condition of the patients and causing great anxiety in their family members. Terminal cancer patients, according to the principle of palliative care and the symptoms of pain, are usually given morphine-like analgesics orally or by injection to ease the pain, and are therefore very likely to suffer from constipation, poor appetite, bloating and other relevant symptoms. The Chinese herbal composition of rhubarb and licorice extracts presented in this study can notably improve the symptoms of constipation, poor appetite, and bloating, and these results are statistically significant.

The invention discloses a compound analgesic preparation containing cobotide and oxycodone. Calculated by weight components, the compound analgesic preparation consists of 0.04-0.08 parts of cobotide and 4-12 parts of oxycodone active ingredients raw materials, and the active ingredients of the oxycodone are oxycodone and pharmaceutically acceptable salts thereof. It has been proved by experiments that the compound analgesic preparation of the present invention can improve chronic pains such as advanced cancer pain, chronic arthralgia, sciatica, neuropathic headache, trigeminal neuralgia, leprosy reaction neuralgia, etc., and is especially suitable for chronic, intractable, persistent Pain, has the characteristics of fast onset, strong and long-lasting analgesic effect, can avoid or reduce adverse reactions such as addiction and dependence, and has high stability, indicating that the compound analgesic preparation containing cobotide and oxycodone can be used as a cancer An ideal drug for pain such as analgesics.

The invention relates to a soft capsule containing toad-cortex, and the capsule takes soybean oil as an oleaginous base, so that the stability and the bioavailability of the capsule are improved significantly. The toad-cortex ultra-micro powder soft capsule is used for treating cancers, wherein the cancers are solid tumors, preferably liver cancers, lung cancers, breast cancers, esophagus cancers, stomach cancers, nasopharyngeal cancers, ovarian cancers, rectal cancers, uterine cancers, cardiac cancers, gliomas and other cancers, and more preferably liver cancers, lung cancers, breast cancers, esophagus cancers, stomach cancers, rectal cancers, uterine cancers and cardiac cancers, and the effects for terminal cancer patients with gastrectasia and vomit are particularly obvious. The toad-cortex ultra-micro powder soft capsule can not only show the amazing treatment effect for diseases-tumors perplexing human beings, but also utilize the toad-cortex based on the natural exuviation phenomenon of toads, thereby not only effectively utilizing resources, but also protecting the ecological environment.

The invention provides external liniment for treating pain caused by terminal cancer tumors and a preparation method of the external liniment. The external liniment comprises the following ingredients by mass: 1 to 3 parts of borax, 1 to 3 parts of dried alum, 1 to 3 parts of borneol and 1 to 3 parts of 95% alcohol. The preparation method comprises the following steps: selecting high-grade clean first-level borax, dried alum, borneol, and 95% alcohol in parts by mass; removing impurities and dust from the borax, the dried alum and the borneol for standby use; melting the purified borneol in the alcohol; adding the purified borax and the purified dried alum; mixing to obtain the external liniment (the longer the placing time is, the better the effect is).

The invention discloses a traditional Chinese medicine composition for treating cancers. The traditional Chinese medicine composition consists of the following components in percentage by weight: 12-16% of almonds, 5-9% of ground beetles, 1-3% of leeches, 1-3% of rheum officinale, 8-12% of sculellaria barbata, 6-10% of root of rehmannia, 6-10% of dried lacquer, 7-12% of gadflies, 1-3% of pseudo-ginseng, 6-9% of radix paeoniae rubra, 2-6% of air potatoes, 7-12% of grubs, 3-8% of liquorice, 2-6% of radix scutellariae and 10-15% of peach kernels, totaling 100%. A preparation method for the traditional Chinese medicine composition comprises the following steps: weighing raw materials, processing the raw materials respectively, baking or drying the processed raw materials and then crushing the braked or dried raw materials into medicine powder and uniformly mixing the medicine powder to obtain the traditional Chinese medicine composition. The traditional Chinese medicine composition can be used for solving the problem that the western medicine treatment easily causes a relapse and is great in toxic and side effect, has obvious effects in treating the liver cancer, the kidney cancer, the intestinal tract cancer, the nasopharynx cancer, the carcinoma of gingival, and various cancers in hypogastrium, is safe and reliable, quick in curative effect and capable of prolonging the lives of terminal cancer patients.

The invention discloses a traditional Chinese medicinal composition with an anti-tumor effect. The traditional Chinese medicinal composition is composed of the following components by weight: 15 to 30parts of Radix codcnopsitis, 15 to 30 parts of milkvetch roots, 10 to 20 parts of Poria cocos, 10 to 20 parts of bighead atractylodes rhizomes, 3 to 6 parts of honey-fried licorice roots, 10 to 20 parts of Radix Paeoniae Alba, 5 to 10 parts of Chinese angelica roots, 5 to 10 parts of Ligusticum wallichii, 5 to 10 parts of Radix Platycodonis, 5 to 10 parts of Radix Angelicae, 15 to 30 parts of Chinese honeylocust spine and 15 to 30 parts of Oldenlandia diffusa. The traditional Chinese medicinal composition provided by the invention has the following advantages: an ancient prescription, namely,Tuoli Xiaodu Powder, is improved and innovatively applied to treatment of malignant tumors; directed at different tumors, syndrome differentiation and treatment are adopted for proportioning and formulation; and clinical experiment results show that the traditional Chinese medicinal composition provided by the invention has good therapeutic effects on a variety of malignant tumors like breast cancer, liver cancer, lung cancer, colon cancer, gastric cancer, ovarian cancer, cervical cancer and endometrial cancer, has significant curative effects on patients with multiple tumors, recurrent tumors and postoperative metastasis, is wide in an application range, free of obvious adverse reactions in clinical practice and safe and reliable in medication, improves the life quality of a terminal cancer patient, and is expected to be developed into a novel anti-tumor traditional Chinese medicine.

Constipation is a common and serious problem for terminal cancer patients, often resulting in deterioration of the overall condition of the patients and causing great anxiety in their family members. Terminal cancer patients, according to the principle of palliative care and the symptoms of pain, are usually given morphine-like analgesics orally or by injection to ease the pain, and are therefore very likely to suffer from constipation, poor appetite, bloating and other relevant symptoms. The Chinese herbal composition of rhubarb and licorice extracts presented in this study can notably improve the symptoms of constipation, poor appetite, and bloating, and these results are statistically significant.

The invention relates to mixed liquor prepared from a tumor total nutrient formula. The mixed liquor is suitably taken during the recovery stage after surgery, radiotherapy, chemotherapy and hospital discharge, patients with malignant tumors have symptoms of malnutrition characterized by weight loss due to factors of tumor consumption, feeding and digestion blocking, effects of tumors on appetite and dysthymic disorder, and the patients can be supplemented with the mixed liquor. The product with the specific total-nutrient formula can provide daily needed nutrients for patients, and is especially suitable for patients with terminal cancers during the recovery stage after surgery, radiotherapy and chemotherapy in hospitals and hospital discharge.

The invention discloses a plaster for treating pain caused by a cancer. The plaster is prepared from the following raw herbal materials: Herba Hedyotidis Diffusae 130 parts, Spina Gleditsiae 60 parts, Rhizoma Sparganii 70 parts, Rhizoma Curcumae 70 parts, Rhizoma Chuanxiong 70 parts, Herba Solani Lyrati 130 parts, Herba Scutellariae Barbatae 120 parts, Pheretima aspergillum 70 parts, Zaocys 70 parts, Rhizoma Paridis 90 parts, Semen Strychni 50 parts, Radix Aconiti 50 parts, Radix Kansui 50 parts, Olibanum 50 parts, Sanguis Draxonis 40 parts, Radix Notoginseng 40 parts, Flos Caryophylli 40 parts, Sal Ammoniacus 40 parts and Scolopendra 40 parts. The plaster can effectively relieve pain caused by the cancer. During treatment, the plaster is applied to a focus of infection and acupuncture points such as the Shenque acupoint, Feishu acupoint, Huagai acupoint, Tanzhong acupoint and Dashu acupoint, and is changed every seven days. For a patient suffering from a terminal cancer, pain of the patient can be relieved after 8-24 hours if the patient uses the plaster. The plaster not only can change mental outlook of the patient, but also brings various conveniences and spiritual comfort for relatives of the patient.

The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine for curing intermediate and terminal cancer, which is characterized by comprising cephalotaxus fortunei, common camptotheca fruits, glaucescent fissistigma roots, oldenlandia diffusa, cleavers, eclipta alba, desmodium, herba patriniae, nidus vespae, centipeda minima, subprostratesophora, ganoderma multiplicatum and iphigenia indica. The thirteen traditional Chinese medicines are prepared into traditional Chinese medicine powder after purifying cleaning, treating, drying in the air, powdering and mixing procedures, and then the powder is mixed properly. The powder can be taken orally and directly, and also can be prepared into traditional Chinese oral liquid for being taken orally after being added into water and boiled with slow fire. The traditional Chinese medicine disclosed by the invention has low cost and excellent effect, has no toxic side effect, can improve the immunologic function of a patient, gradually reduces a cancerous swelling lump, relieves the pain of the patient, prolongs the survival period of the cancerous person, and is suitable for various cancerous people and especially for intermediate and terminal cancerous people.

The invention aims to provide a non-narcotic medicine which can be taken for a long term and is used for treating pains and fevers of terminal cancer patients and a preparation method thereof. The medicine is prepared from the following raw materials in parts by weight: 10-20 parts of cinnabar, 9-30 parts of oyster shell, 10-20 parts of pseudo-ginseng, 10-25 parts of ginseng, 25-30 parts of glossy ganoderma, 18-30 parts of American ginseng, 9-12 parts of radix sophorae tonkinensis, 9-12 parts of red halloysite, 9-15 parts of barbary wolfberry fruit, 3-9 parts of pinellia tuber, 15-20 parts of radix astragali, 15-25 parts of glossy privet fruit, 15-20 parts of basic lead carbonate, 60-90 parts of gordon euryale seed, 10-20 parts of limonitum, 15-20 parts of Chinese yam, 10-25 parts of cinnamon and 150-200 parts of bitter wine. The preparation method is characterized by weighing the active pharmaceutical ingredients according to the ratio, putting the active pharmaceutical ingredients into an earthen pot, adding 1000ml of water to immerse the active pharmaceutical ingredients for 90 minutes, decocting the active pharmaceutical ingredients with soft fire for 60 minutes, filtering the decoction and taking the soup; then adding 800ml of water, decocting the active pharmaceutical ingredients with soft fire for 45 minutes, filtering the decoction and taking the soup; and combining the two soups and adding the bitter wine, thus obtaining the drug.

The invention discloses a traditional Chinese medicine for treating cancer. The traditional Chinese medicine for treating cancer is prepared from poria cocos, radix codonopsis, rhizoma atractylodis macrocephalae, herba solidaginis, radix angelicae sinensis, herba scutellariae barbatae, radix glycyrrhizae, pangolin scales, radix et rhizoma rhei, pseudo-ginseng, radix stephaniae tetrandrae, radix curcumae, chaulmoogratree seeds, semen momordicae and radix gentianae. The traditional Chinese medicine for treating cancer has the advantages that the cost is low, the treatment expense is low, the treatment effect is good, an obvious analgesic effect is achieved for treating liver cancer, stomach cancer, intestinal cancer, lung cancer and pancreatic cancer, and by improving the immunity of a patient, a relapse prevention effect is achieved after the cancer patient takes the medicine after operations or chemoradiotherapy. After a terminal cancer patient takes the medicine, pain can be reduced,and life can be prolonged; after an early cancer patient takes the medicine, a good treatment effect is also achieved.

The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine for curing intermediate and terminal cancer, which is characterized by comprising cephalotaxus fortunei, common camptotheca fruits, glaucescent fissistigma roots, oldenlandia diffusa, cleavers, eclipta alba, desmodium, herba patriniae, nidus vespae, centipeda minima, subprostratesophora, ganoderma multiplicatum and iphigenia indica. The thirteen traditional Chinese medicines are prepared into traditional Chinese medicine powder after purifying cleaning, treating, drying in the air, powdering and mixing procedures, and then the powder is mixed properly. The powder can be taken orally and directly, and also can be prepared into traditional Chinese oral liquid for being taken orally after being added into water and boiled with slow fire. The traditional Chinese medicine disclosed by the invention has low cost and excellent effect, has no toxic side effect, can improve the immunologic function of a patient, gradually reduces a cancerous swelling lump, relieves the pain of the patient, prolongs the survival period of the cancerous person, and is suitable for various cancerous people and especially for intermediate and terminal cancerous people.

The invention provides a traditional Chinese medicine composition for treating cancers. The traditional Chinese medicine composition comprises the following raw materials: lucid ganoderma, blackberry lily, root of red-rooted salvia, red ginseng, ginseng, codonopsis pilosula, angelica root, puffball, root of common peony, curcuma aromatica, radix scutellariae, poria cocos, curcuma zedoary, bulb of thunberg fritillary, garden balsam, dandelion, cortex moutan, cinnabar, dried body of ground beetle, trogopterus dung, paris polyphylla, cordyceps sinensis, pangolin, elecampane, rhizoma corydalis, leeches, nightshade and selaginella doederleinii hieron. By taking the traditional Chinese medicine composition, the immunity of patients can be improved and the capability of killing cancer cells by leukocytes of a human body can be enhanced; the traditional Chinese medicine composition has the effects of tonifying internal organs, calming the nerves, removing swelling and pain, promoting vital energy circulation, removing obstruction in collaterals, gradually reducing lump, easing pain of patients, improving survival quality and prolonging life; by improving the immunity of the patients, the cancer cells can be removed by the autoimmunity of the patients; the traditional Chinese medicine composition has an effect of preventing relapse after being taken by the cancer patients subjected to operation and chemoradiotherapy; the traditional Chinese medicine composition has the effects of reducing pain and prolonging life for the terminal cancer patients; the traditional Chinese medicine composition also has a relatively good treatment effect on the early cancer patients.